| Ifosfamide studied in …STUDIED_INderived200 of 314show all (up to 200) |
|---|
| → studied in | NCT03418038Phase 2 · recruiting Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · 314 trials list this drug (50 active) | — | — | Lymphoma,Hodgkin Lymphoma,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07194044Phase 1 · recruiting Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes · 314 trials list this drug (50 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981899Phase 1/Phase 2 · active not recruiting A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04684368Phase 2 · recruiting A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT · 314 trials list this drug (50 active) | — | — | Mixed Germ Cell Tumor,Central Nervous System Nongerminomatous Germ Cell Tumor,Choriocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823491Phase 3 · not yet recruiting Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall · 314 trials list this drug (50 active) | — | — | Liposarcoma,Soft Tissue Sarcoma,Undifferentiated Pleomorphic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665765Phase 2 · active not recruiting Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Transformed B-Cell Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,Diffuse Large B-Cell Lymphoma Unclassifiable | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05533775Phase 1/Phase 2 · recruiting A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Mature B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05813327Phase 1 · terminated Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02305654Phase 3 · active not recruiting International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) · 314 trials list this drug (50 active) | — | — | Penile Squamous Cell Carcinoma, Usual Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528496Phase 2 · recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · 314 trials list this drug (50 active) | — | — | Neuroblastoma,Childhood Neuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01959698Phase 1 · active not recruiting Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016871Phase 2 · active not recruiting Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL · 314 trials list this drug (50 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04322318Phase 2 · recruiting A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT · 314 trials list this drug (50 active) | — | — | Anaplastic Kidney Wilms Tumor,Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06647953Phase 3 · recruiting Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma · 314 trials list this drug (50 active) | — | — | Pleuropulmonary Blastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946529Phase 2 · completed Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors · 314 trials list this drug (50 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Desmoplastic Small Round Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820957Phase 2/Phase 3 · active not recruiting Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body · 314 trials list this drug (50 active) | — | — | Ewing Sarcoma,High Grade Sarcoma,Round Cell Sarcoma with EWSR1-non-ETS Fusion+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007147Phase 3 · active not recruiting Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · 314 trials list this drug (50 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792253Phase 3 · recruiting Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07724457Phase 2/Phase 3 · not yet recruiting Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma · 314 trials list this drug (50 active) | — | — | Burkitt Lymphoma,High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03719105early Phase 1 · recruiting Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma · 314 trials list this drug (50 active) | — | — | Aggressive NK-Cell Leukemia,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02227199Phase 1/Phase 2 · completed Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03440567Phase 1 · completed Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma,Mantle Cell Lymphoma,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04199026NA · recruiting Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04947501early Phase 1 · active not recruiting A Study of N9 Chemotherapy in Children With Neuroblastoma · 314 trials list this drug (50 active) | — | — | Childhood Malignant Neoplasm,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01873326Phase 2 · active not recruiting Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · 314 trials list this drug (50 active) | — | — | Malignant Myoepithelioma,Atypical Fibroxanthoma,Fibrosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112916Phase 3 · active not recruiting Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma · 314 trials list this drug (50 active) | — | — | Childhood T Acute Lymphoblastic Leukemia,Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02306161Phase 3 · active not recruiting Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma · 314 trials list this drug (50 active) | — | — | Ewing Sarcoma,Peripheral Primitive Neuroectodermal Tumor of Bone,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05821088Phase 2 · active not recruiting Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma,Gray-Zone Lymphoma,Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07321912Phase 2 · recruiting Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma · 314 trials list this drug (50 active) | — | — | Ewing Sarcoma,Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06905509Phase 2 · recruiting Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,High Grade B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393859Phase 3 · completed Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) · 314 trials list this drug (50 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01871766Phase 2 · active not recruiting Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy · 314 trials list this drug (50 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · 314 trials list this drug (50 active) | — | — | Fibrohistiocytic Neoplasm,Nerve Sheath Neoplasm,Pericytic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02375204Phase 3 · active not recruiting Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Germ Cell Tumor,Malignant Germ Cell Tumor,Mixed Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04833114Phase 3 · completed Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL) · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077285Phase 2 · active not recruiting Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05221645Phase 2 · active not recruiting Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06230224Phase 3 · active not recruiting A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04043494Phase 3 · recruiting International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma · 314 trials list this drug (50 active) | — | — | Childhood Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206671Phase 3 · active not recruiting Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents · 314 trials list this drug (50 active) | — | — | Mature B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04968106Phase 2 · active not recruiting Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864109Phase 2 · active not recruiting Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma · 314 trials list this drug (50 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00864318Phase 2 · completed Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis · 314 trials list this drug (50 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02106988Phase 2 · active not recruiting Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07477457Phase 2 · recruiting A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma · 314 trials list this drug (50 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05991388Phase 2/Phase 3 · recruiting A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231906Phase 3 · completed Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma · 314 trials list this drug (50 active) | — | — | Extraskeletal Ewing Sarcoma,Peripheral Primitive Neuroectodermal Tumor of Bone,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06835049Phase 2 · recruiting Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE) · 314 trials list this drug (50 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05364424Phase 1 · completed A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01602666Phase 2 · completed Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Central Nervous System Nongerminomatous Germ Cell Tumor,Childhood Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04776525Phase 2 · recruiting Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393157Phase 2 · recruiting Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL · 314 trials list this drug (50 active) | — | — | Non-Hodgkin Lymphoma,Burkitt Lymphoma,Diffuse Large B-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03034304Phase 1 · terminated A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors · 314 trials list this drug (50 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Fibrosarcoma,Liposarcoma,Malignant Peripheral Nerve Sheath Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878254Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02329080Phase 2 · completed New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02324296completed PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases · 314 trials list this drug (50 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470223Phase 3 · active not recruiting Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04189952Phase 2 · terminated Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma · 314 trials list this drug (50 active) | — | — | Chronic Lymphocytic Leukemia,Diffuse Large B-Cell Lymphoma,Marginal Zone Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643276Phase 3 · recruiting Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 · 314 trials list this drug (50 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104676Phase 3 · completed Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor,Teratoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936936Phase 2 · completed High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors · 314 trials list this drug (50 active) | — | — | Malignant Testicular Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01464606NA · active not recruiting International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry · 314 trials list this drug (50 active) | — | — | Pleuropulmonary Blastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277924Phase 1/Phase 2 · completed Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas · 314 trials list this drug (50 active) | — | — | Bone Sarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04154189Phase 2 · completed A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma · 314 trials list this drug (50 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06489808Phase 2 · recruiting Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02628405Phase 1/Phase 2 · unknown R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Transformed Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02348216Phase 1/Phase 2 · completed Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma,Primary Mediastinal Large B-Cell Lymphoma,High Grade B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04625907Phase 1/Phase 2 · recruiting FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma · 314 trials list this drug (50 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01979536Phase 2 · completed Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Anaplastic Large Cell Lymphoma, ALK-Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05711628Phase 3 · withdrawn A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01505569NA · completed Auto Transplant for High Risk or Relapsed Solid or CNS Tumors · 314 trials list this drug (50 active) | — | — | Germ Cell Tumor,Central Nervous System Neoplasm,Hepatoblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00007865Phase 2 · completed Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06164327Phase 1 · unknown Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574496Phase 2 · completed Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02018861Phase 1/Phase 2 · completed A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039130Phase 2 · completed Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia · 314 trials list this drug (50 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00667342Phase 2 · completed A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma · 314 trials list this drug (50 active) | — | — | Osteosarcoma,Undifferentiated High Grade Pleomorphic Sarcoma of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006734Phase 3 · completed Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788125Phase 1/Phase 2 · terminated Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors · 314 trials list this drug (50 active) | — | — | Childhood Germ Cell Tumor,Childhood Solid Neoplasm,Extragonadal Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02432274Phase 1/Phase 2 · completed Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma · 314 trials list this drug (50 active) | — | — | Neoplasm,Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274924Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00134030Phase 3 · completed Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma · 314 trials list this drug (50 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03077828Phase 2 · unknown Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Nodular Sclerosis Classical Hodgkin Lymphoma,Lymphocyte-Rich Classical Hodgkin Lymphoma,Mixed Cellularity Classical Hodgkin Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05784987NA · unknown R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00199056Phase 4 · completed German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) · 314 trials list this drug (50 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00199095Phase 4 · completed Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia · 314 trials list this drug (50 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00199069Phase 4 · completed German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93) · 314 trials list this drug (50 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02099175Phase 2 · unknown Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02099188Phase 2 · unknown Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346125NA · completed PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703272Phase 3 · terminated A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03064867Phase 1/Phase 2 · active not recruiting Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05590572Phase 1/Phase 2 · not yet recruiting A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma · 314 trials list this drug (50 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044222Phase 3 · unknown A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00199082Phase 4 · completed Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults · 314 trials list this drug (50 active) | — | — | Mediastinal Neoplasm,Burkitt Leukemia,Lymphoblastic Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03736616Phase 2 · unknown Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04475016Phase 2 · completed TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer · 314 trials list this drug (50 active) | — | — | Malignant Penile Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006455Phase 3 · completed Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01117441Phase 3 · completed International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia · 314 trials list this drug (50 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00432094Phase 2 · completed Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Childhood Germ Cell Tumor,Teratoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346164Phase 3 · completed Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Malignant Peripheral Nerve Sheath Tumor,Adult Fibrosarcoma,Adult Liposarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026220Phase 3 · completed Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Childhood Hodgkin Lymphoma,Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02471911Phase 1 · completed KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02050919Phase 2 · completed Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Adult Soft Tissue Sarcoma,Pleomorphic Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02686346Phase 1/Phase 2 · completed Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE · 314 trials list this drug (50 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954174Phase 3 · unknown Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer · 314 trials list this drug (50 active) | — | — | Mixed Mesodermal (Mullerian) Tumor,Primary Peritoneal Carcinoma,Malignant Fallopian Tube Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02808247Phase 2 · terminated Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01156883NA · completed Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia · 314 trials list this drug (50 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02732015Phase 2 · terminated Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324467Phase 2 · unknown Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment · 314 trials list this drug (50 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00302003Phase 3 · completed Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma · 314 trials list this drug (50 active) | — | — | Hodgkin Lymphoma,Childhood Hodgkin Lymphoma,Childhood Favorable Prognosis Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381940Phase 2 · completed Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy · 314 trials list this drug (50 active) | — | — | Adult Hodgkin Lymphoma,Adult Nodular Lymphocyte Predominant B-Cell Lymphoma,Childhood Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002566Phase 3 · completed Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003683Phase 2 · completed Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer · 314 trials list this drug (50 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003860Phase 2 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer · 314 trials list this drug (50 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01169636Phase 1/Phase 2 · completed Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02544425Phase 2 · unknown VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT) · 314 trials list this drug (50 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03283696Phase 1 · completed A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00598169Phase 1 · completed Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00880542Phase 2 · terminated Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02414685Phase 2 · completed First Line TIP in Poor Prognosis TGCTs. · 314 trials list this drug (50 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003086Phase 1/Phase 2 · terminated Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer · 314 trials list this drug (50 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04356872Phase 2 · unknown The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01329900Phase 2 · completed Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02677116Phase 1 · completed A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044378Phase 1/Phase 2 · withdrawn Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma · 314 trials list this drug (50 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967369Phase 2 · completed Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. · 314 trials list this drug (50 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720109Phase 2/Phase 3 · completed Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 314 trials list this drug (50 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01446809NA · completed Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638428Phase 2 · unknown Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy · 314 trials list this drug (50 active) | — | — | Childhood Solid Neoplasm,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367143Phase 2 · unknown Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL · 314 trials list this drug (50 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245011Phase 2 · completed Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354744Phase 3 · completed High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002974Phase 2 · completed Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02441309Phase 2 · terminated A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS) · 314 trials list this drug (50 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02137096Phase 3 · terminated Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma · 314 trials list this drug (50 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02592876Phase 2 · terminated Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | B-Cell Malignant Neoplasm,Lymphoma,Grade 3b Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02718482Phase 2 · terminated Phase II Trial for the Treatment of Relapsed Osteosarcoma · 314 trials list this drug (50 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061893Phase 2 · completed Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00484601Phase 2 · terminated Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma · 314 trials list this drug (50 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00231842Phase 2 · completed Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus · 314 trials list this drug (50 active) | — | — | Malignant Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03349346Phase 1 · withdrawn Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002835Phase 3 · completed Combination Chemotherapy in Treating Patients With Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002565Phase 3 · completed Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00283621NA · completed Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00662233early Phase 1 · completed Combination Chemotherapy in Treating Patients With Sarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00809341Phase 2 · terminated R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma · 314 trials list this drug (50 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01590732Phase 1 · completed Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Anaplastic Large Cell Lymphoma,Hepatosplenic T-Cell Lymphoma,Mycosis Fungoides+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03628131Phase 1/Phase 2 · unknown Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors · 314 trials list this drug (50 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00304083Phase 2 · completed Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02784015Phase 2 · unknown Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822848Phase 1 · completed Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00467051Phase 2 · completed Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Ovarian Germ Cell Tumor,Childhood Extracranial Germ Cell Tumor,Childhood Malignant Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03360760NA · unknown Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum · 314 trials list this drug (50 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00960063Phase 1 · terminated A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) · 314 trials list this drug (50 active) | — | — | Neoplasm,Solid Neoplasm,Malignant Bone Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002865Phase 2 · completed High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia · 314 trials list this drug (50 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03071822Phase 4 · unknown Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas · 314 trials list this drug (50 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392834Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089544Phase 2 · terminated Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall · 314 trials list this drug (50 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354107Phase 1/Phase 2 · terminated Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Anaplastic Large Cell Lymphoma,Childhood Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047320Phase 2 · completed Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Central Nervous System Neoplasm,Childhood Germ Cell Tumor,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02219737Phase 1 · completed Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma · 314 trials list this drug (50 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01097057Phase 2 · completed Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells · 314 trials list this drug (50 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00623077Phase 1 · terminated MT2004-30: Tomotherapy for Solid Tumors · 314 trials list this drug (50 active) | — | — | Sarcoma,Malignant Kidney Neoplasm,Malignant Liver Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470366Phase 2 · completed Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor,Teratoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746992Phase 4 · unknown CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Anaplastic Large Cell Lymphoma, ALK-Negative,Hepatosplenic T-Cell Lymphoma,Subcutaneous Panniculitis-Like T-Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01055314Phase 2 · completed Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma · 314 trials list this drug (50 active) | — | — | Adult Soft Tissue Sarcoma,Childhood Soft Tissue Sarcoma,Adult Rhabdomyosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02408042Phase 1/Phase 2 · withdrawn Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) · 314 trials list this drug (50 active) | — | — | Lymphoma,Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601718Phase 1/Phase 2 · completed Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Anaplastic Large Cell Lymphoma,Non-Hodgkin Lymphoma,Adult Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002601Phase 2 · completed Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002931Phase 2 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer · 314 trials list this drug (50 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor,Teratoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003657Phase 2 · completed High-dose ICE With Amifostine · 314 trials list this drug (50 active) | — | — | Adult Solid Neoplasm,Extragonadal Germ Cell Tumor,Malignant Head and Neck Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01331590early Phase 1 · completed Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia · 314 trials list this drug (50 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00920153Phase 3 · terminated Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039195Phase 2 · completed Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002494Phase 2 · completed Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia · 314 trials list this drug (50 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072215Phase 3 · terminated Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812654Phase 2 · unknown Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment · 314 trials list this drug (50 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003852Phase 2 · terminated Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Childhood Germ Cell Tumor,Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02771743Phase 2 · unknown Response-based Treatment of High-risk Neuroblastoma · 314 trials list this drug (50 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002558Phase 1/Phase 2 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors · 314 trials list this drug (50 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423852Phase 1/Phase 2 · completed Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin · 314 trials list this drug (50 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor,Teratoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01490060NA · completed Fosaprepitant in Patients Receiving Ifosfamide-based Regimen · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002546Phase 3 · completed Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255723Phase 2 · completed Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003631Phase 2 · completed Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00280878Phase 2 · completed Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma · 314 trials list this drug (50 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00796120Phase 3 · completed An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS) · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450801Phase 2 · completed R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00317408NA · unknown Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma · 314 trials list this drug (50 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002854Phase 1 · completed High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer · 314 trials list this drug (50 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00526318NA · unknown Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma · 314 trials list this drug (50 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02422563Phase 3 · unknown NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB · 314 trials list this drug (50 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00529503Phase 2 · terminated A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL · 314 trials list this drug (50 active) | — | — | Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00613457Phase 3 · completed Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia · 314 trials list this drug (50 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01795430NA · withdrawn Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma · 314 trials list this drug (50 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Bone Ewing Sarcoma,Extraskeletal Ewing Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00695032NA · suspended Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors · 314 trials list this drug (50 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061984Phase 3 · completed Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma · 314 trials list this drug (50 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |